Related Experiment Video

Updated: Jun 21, 2026

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

From methods to policy: a critical appraisal of the 2024 ECDC guidance on enhanced influenza vaccines

Raúl Ortiz de Lejarazu1, Daniel Ocaña2, Pilar Arrazola3

  • 1National Influenza Center, Valladolid, Spain.

Frontiers in Public Health
|March 27, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
ECDCinclusion criteriainfluenzamethodological consistencyreviewvaccine

More Related Videos

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies04:47

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on: February 23, 2018

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
53.6K
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
37